Davenport & Co LLC
- SEC CIK
- 0000887777
- Latest filing
- Jul 13, 2026
ESPR holding history
Esperion Therapeutics, Inc. in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ESPR overviewAll 13F holders of ESPRFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −10,000−100.0% | Sold out | Holders |
| Q3 2025 | 10,000 | $26.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 10,000 | $9.84K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,000 | $14.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,000 | $22.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,000 | $16.5K | <0.1% | −20,000−66.7% | Reduced | Holders |
| Q2 2024 | 30,000 | $66.6K | <0.1% | +30,000 | New | Holders |